Xtx Topco LTD Bio Techne Corp Transaction History

Xtx Topco LTD

$1.12 Billion
Q2 2024

A detailed history of Xtx Topco LTD transactions in Bio Techne Corp stock. As of the latest transaction made, Xtx Topco LTD holds 17,043 shares of TECH stock, worth $1.34 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

17,043

Previous 9,011 89.14%

Holding current value

$1.34 Million

Previous $634,000 92.59%

% of portfolio

0.11%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$62.12 - $84.15 $498,947 - $675,892	8,032 Added 89.14%	17,043 $1.22 Million
Q1 2024 May 13, 2024	BUY	$65.98 - $77.09 $256,992 - $300,265	3,895 Added 76.13%	9,011 $634,000
Q4 2023 Feb 13, 2024	SELL	$52.83 - $78.22 $414,926 - $614,339	-7,854 Reduced 60.56%	5,116 $394,000
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $256,575 - $339,796	3,800 Added 41.44%	12,970 $882,000
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $377,724 - $440,303	5,121 Added 126.48%	9,170 $748,000
Q1 2023 May 12, 2023	SELL	$71.62 - $86.62 $86,015 - $104,030	-1,201 Reduced 22.88%	4,049 $300,000
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $423,517 - $1.85 Million	5,250 New	5,250 $435,000
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $418,180 - $582,746	1,296 New	1,296 $449,000
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $303,957 - $419,011	-859 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $391,832 - $451,026	859 New	859 $444,000
Q2 2021 Aug 12, 2021	SELL	$387.35 - $450.26 $428,409 - $497,987	-1,106 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $347,969 - $454,566	1,106 New	1,106 $422,000

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.09B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account